Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1043]

Aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in premenopausal as well as postmenopausal women

Aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in premenopausal...

Early prostate cancers can harbour aggressive tumour cells

Early prostate cancers can harbour aggressive tumour cells

Researchers show increased survival rate in prostate cancer patients with addition of hormone therapy treatments

Researchers show increased survival rate in prostate cancer patients with addition of hormone therapy treatments

Breast cancer patients with oestrogen receptor mutations may benefit from early switch to fulvestrant/palbociclib

Breast cancer patients with oestrogen receptor mutations may benefit from early switch to fulvestrant/palbociclib

SABCS 2021: Breast cancer patients with oestrogen receptor mutations may benefit from early switch to fulvestrant/palbociclib

SABCS 2021: Breast cancer patients with oestrogen receptor mutations may benefit from early switch to fulvestrant...

SABCS 2021: Elacestrant may improve outcomes for patients whose metastatic breast cancers progressed on prior endocrine therapy

SABCS 2021: Elacestrant may improve outcomes for patients whose metastatic breast cancers progressed on prior...

Finnish researchers developed mini-breast cancer as a new weapon against the most common type of breast cancer

Finnish researchers developed mini-breast cancer as a new weapon against the most common type of breast cancer

Possible new treatment option discovered for aggressive forms of breast cancer

Possible new treatment option discovered for aggressive forms of breast cancer

Genetic biomarker test predicts recurrence and survival outcomes for men with high-risk prostate cancer

Genetic biomarker test predicts recurrence and survival outcomes for men with high-risk prostate cancer

Daily use of cannabidiol (‘CBD’) oil may be linked to lung cancer regression

Daily use of cannabidiol (‘CBD’) oil may be linked to lung cancer regression

More from ecancer